Craig fue aceptado en un ensayo cerca de su zona y avanz hasta una dosis semanal de 12 mg de retatrutida, la ms alta ofrecida en los ensayos de fase II de Lilly
Our providers will start you on a lower dose and gradually increase it to minimize side effects, while providing ongoing support and management strategies
Subsequent trials demonstrated cardiovascular benefits: in the SUSTAIN 6 trial, semaglutide reduced major adverse cardiovascular events by 26% in high-risk patients, a finding that led to FDA approval for cardiovascular risk reduction in January 2020
Our goal is to provide clarity on the link between GLP-1 medications and dizziness so you can move forward with confidence
This remains an open question in the retatrutide research program
Both are reasonable, clinician-led options, and the better fit comes down to how you want to pay and how much hands-on contact you want